|
|
|
 |
|
|
 |
 |
Medarex Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Medarex Incorporated. The Group's principal activities are to discover and develop human antibody-based therapeutic products. The Group uses its proprietary technology platform, the UltiMAb Human Antibody Development System to rapidly create and develop therapeutic products for the treatment of cancer, inflammation, auto-immune disease and other life-threatening and debilitating diseases. The Group's therapeutic product candidates are currently under development and include MDX-33, MDX-010, HuMax(TM)-CD4, HuMax-IL15, Centocor/J&J Antibody and MDX-070. As of 01-Feb-2008, the Group had licensing and collaborative partnerships with more than 35 pharmaceutical and biotechnology companies either to jointly develop and commercialize products or use the Group's proprietary technology in the development of new therapeutic products.
|
|
| |
Wright Quality Rating:
LBNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (9/1/2009):
16.02
(Figures in
U.S. Dollars) |
|
1 Week |
0.3% |
|
13 Weeks |
0.9% |
|
|
|
|
|
|
|
|
|
4 Weeks |
115.6% |
|
52 Weeks |
134.6% |
|
|
|
| |
| |
Medarex Incorporated
Key Data: |
|
|
|
| |
Ticker: |
MEDX |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2008
Sales |
52,292,000
(Year Ending Jan 2009). |
Employees: |
488 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
N/A |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
N/A |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
N/A |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Medarex Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Medarex Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Medarex Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Medarex Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Medarex Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|